Corient Capital Partners’s Barclays BCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$193K Hold
25,366
0.01% 617
2022
Q2
$193K Buy
25,366
+8,433
+50% +$66.2K 0.01% 633
2022
Q1
$134K Sell
16,933
-5,829
-26% -$59.5K 0.01% 707
2021
Q4
$236K Buy
22,762
+5,306
+30% +$55.7K 0.02% 605
2021
Q3
$180K Sell
17,456
-4,429
-20% -$44.1K 0.01% 652
2021
Q2
$211K Buy
21,885
+9,214
+73% +$94.1K 0.02% 612
2021
Q1
$130K Buy
+12,671
New +$111K 0.01% 595
2020
Q4
Sell
-21,421
Closed -$107K 535
2020
Q3
$107K Sell
21,421
-15
-0.1% -$83 0.01% 473
2020
Q2
$121K Buy
+21,436
New +$112K 0.01% 463
2020
Q1
Sell
-30,942
Closed -$295K 414
2019
Q4
$295K Buy
30,942
+3,041
+11% +$26.3K 0.04% 360
2019
Q3
$205K Buy
27,901
+3,142
+13% +$22.7K 0.03% 407
2019
Q2
$185K Buy
24,759
+13,171
+114% +$104K 0.03% 373
2019
Q1
$91K Buy
+11,588
New +$93.1K 0.01% 342

Other funds holding BCS

Corient Capital Partners's BCS Position: Q3 2022 in Review

Corient Capital Partners held its Barclays (BCS) position steady in Q3 2022 at 25,366 shares worth $193K. The position accounts for 0.01% of the portfolio, ranked #617.

Corient Capital Partners first reported a position in BCS in Q1 2019 and has held it in 13 quarters since. The position peaked at $295K in Q4 2019. 273 funds tracked by Wall St. Rank hold BCS as of Q3 2022.

  • Corient Capital Partners held 25,366 shares of Barclays worth $193K as of Q3 2022.
  • Corient Capital Partners left its Barclays share count unchanged in Q3 2022.
  • Barclays made up 0.01% of Corient Capital Partners's portfolio in Q3 2022, its #617 holding.
  • Corient Capital Partners first reported a position in Barclays in Q1 2019 and has held it in 13 quarters since.
  • Corient Capital Partners's Barclays position peaked at $295K in Q4 2019.
  • 273 funds tracked by Wall St. Rank held Barclays as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.